Eddie is a co-founder and CEO of Akili Interactive, a leading digital medicine company creating prescription treatments for people living with cognitive disorders that are delivered through immersive action video game experiences. Akili is currently developing technologies to treat medical conditions across neurology and psychiatry, including ADHD, depression, autism and various inflammatory diseases. Prior to starting Akili in 2011, Eddie co-founded two other health-focused start-ups with PureTech Health, and helped launch the firm’s digital health initiative. He was previously a Kauffman Entrepreneur Fellow, a program sponsored by the Kauffman Foundation of Kansas City, MO, focused on healthcare entrepreneurship. Prior to that, he completed his graduate work at Yale University in the Departments of Pharmacology and Molecular Biophysics & Biochemistry, focusing on structure-based drug design. Eddie received his B.S. in Biochemistry from Providence College, and his M.Phil. and Ph.D. from Yale University. Eddie frequently serves on discussion panels for industry and academic events related to healthcare innovation, has appeared in media including CNN’s Vital Signs with Sanjay Gupta, and Akili has received recognition including the 2014 Future of Health Technology product award, 2015 50-on-Fire Boston, #1 health company in Entrepreneur magazine’s 100 Brilliant Companies of 2016, CNS Summit 2017 Innovation Award winner, 2018 Xconomy Innovation at the Intersection award finalist, 2018 Bostonfest Coolest Companies finalist and 2018 Business Intelligence Best Places to Work Finalist.